We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHRT icon
3101
iHeartMedia
IHRT
$583M
$0 ﹤0.01%
5
-466
-99% -$9.29K
IIIV icon
3102
i3 Verticals
IIIV
$342M
$0 ﹤0.01%
7
-205
-97% -$5.05K
IMCC
3103
IM Cannabis
IMCC
$1.12M
$0 ﹤0.01%
+1
New +$136
IMUX icon
3104
Immunic
IMUX
$195M
0
IMVT icon
3105
Immunovant
IMVT
$8.25B
-382
Closed -$3K
INDI icon
3106
indie Semiconductor
INDI
$854M
-20
Closed
INMD icon
3107
InMode
INMD
$880M
-206
Closed -$9.23K
INSM icon
3108
Insmed
INSM
$28.6B
-119
Closed -$3K
INVA icon
3109
Innoviva
INVA
$1.48B
-189
Closed -$3K
IPAR icon
3110
Interparfums
IPAR
$3.94B
-6
Closed -$1K
IRBT
3111
DELISTED
iRobot
IRBT
-2
Closed
IRMD icon
3112
iRadimed
IRMD
$1.18B
$0 ﹤0.01%
2
-55
-96% -$2.54K
ITGR icon
3113
Integer Holdings
ITGR
$4.26B
$0 ﹤0.01%
2
IVR icon
3114
Invesco Mortgage Capital
IVR
$805M
$0 ﹤0.01%
21
IVVD icon
3115
Invivyd
IVVD
$218M
-10
Closed
JYNT icon
3116
The Joint Corp
JYNT
$119M
-21
Closed -$1K
KALA icon
3117
KALA BIO
KALA
$14.5M
0
KALU icon
3118
Kaiser Aluminum
KALU
$3.02B
$0 ﹤0.01%
1
KE
3119
Kimball Electronics
KE
$628M
$0 ﹤0.01%
13
-246
-95% -$4.77K
KNSA icon
3120
Kiniksa Pharmaceuticals
KNSA
$5.93B
-24
Closed
KOS icon
3121
Kosmos Energy
KOS
$1.48B
$0 ﹤0.01%
68
KPTI icon
3122
Karyopharm Therapeutics
KPTI
$48M
-22
Closed -$2K
KRBN icon
3123
KraneShares Global Carbon Strategy ETF
KRBN
$143M
-50
Closed -$3K
KRO icon
3124
KRONOS Worldwide
KRO
$989M
$0 ﹤0.01%
15
-296
-95% -$4.4K
KVHI icon
3125
KVH Industries
KVHI
$157M
$0 ﹤0.01%
29

Similar funds

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.